in Philadelphia-Chromosome-Negative Acute Lymphoblastic Leukemia, Late Relapses Are Not Uncommon, Occur Mostly in Patients at Standard Risk and Have a Relatively Favorable Outcome. Results of the International ALL Trial: MRC Ukallxii/ECOG E2993
Year: 2015
Type: article
Source: Blood
Authors: Chezi Ganzel, Wang Xin Victoria, Adele K. Fielding, Jacob M. Rowe, Susan M Richards, Georgina Buck, Rajesh Chopra, I. Jill Durrant, David Marks, Ian M. Franklin, Andrew K McMilan, Mark R Litzow, Elisabeth Paietta, Selina Luger, Peter H Wiernik, Dan Douer, Hillard M. Lazarus, Martin S Tallman, Anthony H. Goldstone
Institutions: Shaare Zedek Medical Center, Bikur Cholim Hospital, Dana-Farber Cancer Institute, The Royal Free Hospital, University College London, Technion – Israel Institute of Technology, University of Oxford, National Health Service, The Christie Hospital, Bristol Royal Hospital for Children, University of Glasgow, Nottingham University Hospitals NHS Trust, Mayo Clinic, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Abramson Cancer Center, University of Pennsylvania, Mount Sinai Beth Israel, Albert Einstein College of Medicine, Memorial Sloan Kettering Cancer Center, University Hospitals Cleveland Medical Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2530417741